JOINN Biologics

Executive Summary

JOINN Biologics is a US-based Contract Development and Manufacturing Organization (CDMO) specializing in complex biologics, offering integrated services from DNA to drug product. Founded in 2015 and headquartered in San Francisco, the company operates facilities in Richmond and Sacramento, California, and leverages a close collaboration with its sister CRO, JOINN Labs, to deliver quality, speed, and value. Despite being in the pre-clinical stage as a private entity, JOINN Biologics is well-positioned to capture growing demand for biologics manufacturing, particularly among emerging biotech firms seeking flexible, high-quality outsourcing partners. The company's focus on complex biologics and its integrated service model differentiate it in a competitive CDMO landscape. However, as a private company with limited public information, its financial performance and pipeline visibility remain opaque. Future growth will depend on securing additional client contracts, expanding capacity, and potentially raising capital to scale operations.

Upcoming Catalysts (preview)

• Q3 2026Announcement of Major Client Contract or Partnership60% success
• Q4 2026Facility Expansion or Capacity Addition50% success
• H2 2026Securing Series B or Growth Funding45% success